Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q2 2018 |
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
EQRx, Inc. | 4 | Q3 2022 | 61.9% |
Nautilus Biotechnology, Inc. | 4 | Q3 2022 | 40.8% |
Erasca, Inc. | 4 | Q3 2022 | 20.3% |
InVitae Corporation | 4 | Q3 2022 | 9.3% |
View AH Equity Partners Bio II, L.L.C.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
4 | 2023-11-09 |
4 | 2023-01-04 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
3 | 2021-12-22 |
3 | 2021-06-09 |
View AH Equity Partners Bio II, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.